The latest from OTC Perspectives
The Power of Positioning
Wednesday, 13 May 2009, 12:38 PM
The Power of Positioning – The Mucinex Story – an exclusive presentation to OTC National delegates by Bob Casale, CEO, Scerene Healthcare
read more
How to Compete against Private Label and Win at Retail
Wednesday, 13 May 2009, 12:35 PM
An exclusive presentation by Gary Charboneu at the OTC National Conference June 4-5, 2009 at the Boston Sheraton Hotel read more
OTC Perspectives Magazine Names Top Consumer Health Care Marketers of the Year
Friday, 08 May 2009, 10:06 AM
FLORHAM PARK, N.J. (May 8, 2009) — OTC Perspectives Magazine, the new publication created by consumer healthcare marketers for consumer healthcare marketers, has named its inaugural annual list of “The Top OTC/Healthcare Marketers of the Year.” read more
J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards
Wednesday, 01 April 2009, 12:19 PM
FLORHAM PARK, NJ (April 2009) — OTC Perspectives, Announces Finalists in the 2009 OTC National Advertising Awards. Major Healthcare brands such as Aleve, Benadryl, Claritin, Mucinex,
MiraLAX, Neutrogena, and ZYRTEC are among finalists in the running for top honors in the OTC National Advertising Awards. read more
Introducing OTC Perspectives
Tuesday, 23 December 2008, 01:56 PM
DTC Perspectives Inc., the leading DTC training, publishing and consulting company and producer of the DTC National Conference and DTC Perspectives Magazine, is proud to announce the creation of the OTC (Over-the-Counter) Perspectives Division. OTC Perspectives will serve the unmet needs of OTC Marketers, and provide educational conferences, industry forums to address the key issues and publications designed to focus on a myriad of emerging issues OTC Marketers face in today's complex regulatory and consumer environments. read more
News From DTC Perspectives - PhRMA's Incrementalism
Friday, 12 December 2008, 07:38 AM
On Dec 10, some modifications were announced to the DTC PhRMA 2006 code. The original code had good intent and did address some of the criticisms of DTC. The latest changes, of course, should have been in the original code. They are fairly obvious and somehow were too “radical” to appear in the original.
read more
News from DTC Perspectives - PhRMA Announces Enhanced DTC Guidelines
Wednesday, 10 December 2008, 11:29 AM
PhRMA has revised its three-year-old Guiding Principles for DTC advertising, and will make the changes effective March 2, 2009. The trade association noted that the revisions are a response to “feedback from physician groups, policymakers and other stakeholders,” according to a press release posted Dec. 10 on its Web site. PhRMA’s revisions are an ongoing effort to continue the educational benefit of DTC, as well as to “renew our commitment to work with the Food and Drug Administration and healthcare professionals,” said Billy Tauzin, read more
News from DTC Perspectives - CEOs Blast DTC
Friday, 05 December 2008, 08:25 AM
In these troubled times for pharmaceutical companies, some CEO’s are becoming publicly more critical of industry practices. One is Roche CEO, William Burns. At a Financial Times conference in London on 12/2, Reuters reported Mr. Burns said DTC was the “single worst decision for the industry.” He said this because he apparently believes DTC hurts the credibility of industry claims that it is spending more on R&D than promotion. read more
News from DTC Perspectives - Fair Balance or Scare Balance
Friday, 21 November 2008, 08:23 AM
The Wall Street Journal's Melinda Beck wrote a fascinating column (11/18) on the power of suggestion. Titled “When Drug Labels Make You Sick”, Ms. Beck explores the little studied issue of how reading the litany of side effects actually can make you more prone to disease. The FDA is rightly concerned with informing consumers of the risks they take when beginning use of an Rx drug. All of us are entitled to know if the drugs we are prescribed can kill us or cause debilitating side effects. read more
  1 2 [3] |
| Total: 29 |
